The dysregulation, expression, and clinical implications of p63 in DLBCL are less clear than those of p53; likewise, p63's role in tumorigenesis and its functional relationship with p53 are not well understood. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.